ImmunityBio, Inc. Soared

Thu, Jan 15, 2026 at 07:16 PM

ImmunityBio, Inc. (IBRX:NASDAQ) rocketted at $3.95, a gain of 30.8%. On Thu, Jan 15, 2026, IBRX:NASDAQ touched a New 2-Week High of $3.95. The stock got featured on our News Catalysts scanner on Thu, Jan 15, 2026 at 12:56 PM in the 'BIOTECH' category. From Fri, Jan 02, 2026, the stock recorded 100.00% Up Days and 90.00% Green Days

About ImmunityBio, Inc. (IBRX:NASDAQ)

ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases.

Top 10 Gainers:

Springview Holdings Ltd (SPHL:NASDAQ), 656.96%
Callan JMB Inc. (CJMB:NASDAQ), 275%
Moolec Science SA (MLEC:NASDAQ), 118.13%
Pheton Holdings Ltd (PTHL:NASDAQ), 105.16%
Ambitions Enterprise Management Co. L.L.C (AHMA:NASDAQ), 89.55%
Agape ATP Corporation (ATPC:NASDAQ), 56%
Creative Global Technology Holdings Limited (CGTL:NASDAQ), 52.4%
Bonk Inc Com (BNKK:NASDAQ), 42.45%
ImmunityBio, Inc. (IBRX:NASDAQ), 30.79%
Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 29.23%